Spruce Financial Statements From 2010 to 2026
| SPRB Stock | USD 78.09 2.48 3.08% |
Check Spruce Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spruce Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Spruce financial statements analysis is a perfect complement when working with Spruce Biosciences Valuation or Volatility modules.
Check out the analysis of Spruce Biosciences Correlation against competitors. Spruce Biosciences Common Company Return On Equity Analysis
Spruce Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Spruce Biosciences Return On Equity | -1.68 |
Most of Spruce Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spruce Biosciences Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Spruce Biosciences Common has a Return On Equity of -1.6793. This is 92.99% lower than that of the Biotechnology sector and 95.39% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Spruce Biosciences Common Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spruce Biosciences's current stock value. Our valuation model uses many indicators to compare Spruce Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spruce Biosciences competition to find correlations between indicators driving Spruce Biosciences's intrinsic value. More Info.Spruce Biosciences Common is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spruce Biosciences' earnings, one of the primary drivers of an investment's value.About Spruce Biosciences Financial Statements
Spruce Biosciences stakeholders use historical fundamental indicators, such as Spruce Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Spruce Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spruce Biosciences' assets and liabilities are reflected in the revenues and expenses on Spruce Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spruce Biosciences Common. Please read more on our technical analysis and fundamental analysis pages.
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out the analysis of Spruce Biosciences Correlation against competitors. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spruce Biosciences. If investors know Spruce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spruce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spruce Biosciences Common is measured differently than its book value, which is the value of Spruce that is recorded on the company's balance sheet. Investors also form their own opinion of Spruce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Spruce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spruce Biosciences' market value can be influenced by many factors that don't directly affect Spruce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spruce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spruce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spruce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.